The International journal of nursing Education and palliative science is the perfect source for information on continuing medical education nursing courses for 2017-2018 as well as the most happening worldwide conferences in the field of healthcare.
IJNP 2018 Will Focus on "Unity in the diversity of nursing in leading and advancing global health for Innovations and current challenges". This offers a forum to network and interact with other healthcare professionals, earn credits and stay updated on the hottest advancements in the field. Our database lists national and international conferences, opportunities, speakers and events to customize your experience at the conference as per your preferences and interests.
The International journal of nursing Education and palliative science aim to share information and skill of nursing, midwifery and healthcare personnel all over the world and to influence and inspire students and professionals to work for social care needs of their respective communities.
On behalf of the INTERNATIONAL JOURNAL OF NURSING EDUCATION AND PALLIATIVE SCIENCE, it is our great honor to invite you to join us
Welcome to the keynote forum, plenary speakers, delegates, collaboration, exhibitors, sponsors, the press, and other participants to the INTERNATIONAL JOURNAL OF NURSING EDUCATION AND PALLIATIVE SCIENCE. It’s an exciting time for attending Innovate Nursing 2018 as we continue to grow and adapt, remaining always adaptable, motivated.Our organization is confronting a time of many changes and we’re meeting these changes during a time of larger nation-wide and global change. The world of Nursing and healthcare is an exciting area in which to work on clinical case studies, and we’ll continue to meet and bring inspired people together in forums like this, to ensure ours innovate conference remains at the cutting edge.
Aim and Scope of the journal:
This seeks to attract healthcare professionals working for the growth and establishment of nursing, midwifery and healthcare education, in addition to those who are involved in training healthcare professionals. The conference is open to faculty, nursing and midwifery educationalists, academic administrators, senior education managers, practitioners, researcher, and students.
1 Nursing Teaching Strategies
2 Nursing Management
3 Psychiatric Nurses
4 Peri-Operative Nursing
5 Critical Care Nursing
6 Nursing Types
7 Critical Care for the Nurse Practitioner
8 Nursing Education
9 International Nursing Education
10 Advanced Nursing Practice
11 Disaster Nursing
12 Nursing Practice
13 Pediatric Nursing
14 Clinical Nursing
15 Psychiatric and Mental Health Nursing
16 Emergency Nursing
17 Environmental Health Nursing
18 Cardiac Nursing
19 Risk Factors in Nursing and Healthcare professionals
20 Cardiac Nursing Management
21 Dental Nursing
22 Health Care Technology
23 Nursing Anesthesia
24 Gerontologic Nursing
25 Palliative care
26 Medical decision making and health economics
27 Nephrology Nursing
28 Neonatal nursing
Nursing Scientific Networks:
Nursing Leadership & Committees consider proposals for Special Issues Editors will return a decision on your proposal within Two weeks of receipt. To enrich our vision of making the scientific information available at an ease of access, Nursing Leadership & Committees initiated special issue for the open access journals. All the articles published under a special issue focuses on a single topic providing the complete information about the ongoing research providing more insight on an emphasized topic of research enabling the readers to access wide forecasted information on a particular topic Issue.
Special Issue Proposals: Special Issue deals with focused research topics of high interest, falling under the scope of the Journal. Special Issues are the pool of articles under a current topic selected from the Ongoing Research under specific discipline. The aim of the Special Issue is to provide a platform for the researchers to understand the recent advancements and challenges in particular areas of research. These articles will provide an opportunity to the readers to understand and access the scientific information.
We encourage potential scientists to organize the Special Issue in their field of interests that fit within the Journal scope. This will provide an opportunity to increase the visibility of the Guest Editors. The Special Issue Titles may be from any basic and clinical area of Science, Technology, and Medicine. People interested in publishing a special issue are advised to consider the following guidelines.
Your proposal should contain:
By submitting a Special Issue proposal to Nursing Leadership & Committees, you agree to abide by the Special Issue Editor Protocol should your proposal be accepted
Special issue articles are published immediately upon their acceptance and are released under upcoming regular issues. Special Issues are invited throughout the year. For more information or any queries about the special issues, please write us to email@example.com or firstname.lastname@example.org
Promoting Your Special Issue
Nursing Leadership & Committees will work with Guest Editors to increase the visibility of the Special Issue in the months leading up to the submission deadline and once it has been published.
What Nursing Leadership & Committees will do:
1. Nursing Leadership & Committees will circulate your Call for Papers to the Nursing Editorial Board, targeted mailing lists, and relevant AoM listservs. It will also advertise your Call on the Nursing websites and other social media platforms. It will re-issue the Call at appropriate intervals.
2. Once the Special Issue is published, announcements will be made to the Nursing Editorial Board, targeted mailing lists, and relevant AoM listservs as well as on the Nursing websites social media platforms.
3. Free access to the Special Issue will be made available in the website to Guest Editors and readers.
What is expected of Guest Editors?
1. We expect that Guest Editors will circulate the Call for Papers within their own personal networks, social media groups, and at any relevant conferences or workshops, they may attend.
2. If it has not already been suggested as part of the proposal, consideration should be given to organizing a conference or workshop either to generate submissions or to aid in the development of submitted papers. A symposium or PDW at a well-known conference may also be considered.
3. We expect Guest Editors to identify up to 50 scholars for whom the Special Issue will be particularly relevant
If you have any queries; please contact Stella Lopez (email@example.com)
Teaching basic, clinical and experimental pharmacology through both the traditional as well as integrated problem based learning methods to under and post graduate students of Medicine, Dentistry, Pharmacy and Nursing colleges as well as researching in pharmacology and medicine since 2006. My MSc thesis was entitled: “Effect of nitro-aspirin versus ezetimibe in experimentally induced fatty liver in rats” and the PhD/MD thesis was entitled: “Effect of some antioxidant, antihypertensive and antidiabetic drugs on the toxicity of some antineoplastic drugs in rats”. I really enjoy searching on pharmacotherapy of diabetes, obesity, NAFLD, cancer and autoimmune diseases with special emphasis on pharmacovigilance and drug safety and I’m honored to be the first physician and scientist in the middle east who raised public awareness through newspapers and TV shows about the potential carcinogenicity of the antidiabetic drug pioglitazone which is withdrawn or heavily restricted in the developed countries and unfortunately widely circulating in the developing ones including my county, Egypt. I’ve also practiced general medicine, internal medicine and dermatology in many charitable and private clinics, dispensaries and hospitals since my graduation till this moment.
Mina T Kelleni (2018): Using insulin glargine temporarily to control resistant hyperglycemia induced by mild to moderate bacterial infections in Egyptian type 2
13. Relevant publications and papers: Kelleni MT (2018) HCV Infection in Pediatric Population A Current Brief Synopsis. Pediatr Res Child Health 1: 001-001.diabeticout patients. A real life experience. Gen Med (Los Angeles) 6(1): e116.
Mina T Kelleni (2018): Back to oral hypoglycemic drugs after ten years of insulin injections; An Egyptian case study. J Clin Exp Endocrinol 2(1): e105
Mina TKelleni (2017): Sublaboratory hypothyroidism in Egyptian young adult females with normal TSH levels; what to do? A practical real lifeKelleni MT (2017): Diabetogenic Drugs and Hormones, what Every Physician should know and
experience. J Gen Emerg Med 2(6): 102e.beAware of? Gen Med (Los Angeles) 5: e114.
Mina T Kelleni (2017): Autoimmune Cholangiopathy at a Glance: Diagnosis, Differential Diagnosis and Treatment. Acute Chronic Dis,1:1. 1000e102.
Mina T Kelleni (2017): Idiopathic Hypereosinophilic Syndrome: Etiology, Diagnosis, Manifestationsand Management. J Endocrinol Thyroid Res. 2017; 2(3): 555586.
Mina T. Kelleni (2017): Islet Cell Transplantation for Treating Type 1 Diabetes: The Bright Future of Drug Designing and Development. Nov Appro Drug Des Dev 1(3): NAPDD.MS.ID.555564
Kelleni MT (2017): How the brain-gut axis may connect several cerebro-intestinal co-morbidities: Irritable bowel syndrome and Epilepsy as examples? Int J Gen Med Surg 1(1): 1-3.
Mina T Kelleni (2017): Benefits of green coffee beans extract in health and obesity. SF Obesity Res J 1:1.
Mina T. Kelleni (2017): Avian flu suspected upcoming pandemic: prevention and management. SF J Flu Sci 1:1.
Kelleni MT (2017): Use of Insulin Glargine and Metformin for Prevention of Diabetes and its Cardiovascular Complications. Diabetes Obes Int J 2(2): 000148.
Ibrahim S, Kamel MY, Kelleni MT (2017): Effect of nifedipine and glibenclamide addition in a model ofhigh fat dietinduced hypertension and hyperlipidemia in rabbits receiving donepezil. Int J Sci Res Environ Sci Toxicol 2(1): 4.
Mina T. Kelleni (2017): Type 2 Diabetes Mellitus: a reciprocal mutual interaction with amyloidosis or a presentation of an isolated primary pancreatic amyloidosis? Integr Obesity Diabetes, 3(1): 1-2.doi: 10.15761/IOD.1000165
Kelleni MT (2017): General Medicine, Open Access: A Wonderful 2016 Harvest and New Heights to Look Forward In 2017. Gen Med (Los Angeles) 5:1000e112.
Mina T. Kelleni (2016): Gliflozins:initial review of literature. Integr Obesity Diabetes 2(5): 276-276. DOI: 10.15761/IOD.1000159
Mina T. Kelleni (2016): Pre-Dorsal Myxedema: A Rare Unique Manifestation of Hypothyroidism in an Egyptian Female Patient. J Gen Emerg Med 1(1): 101e.
Mina T Kelleni (2016): Sofosbuvir/Simeprevir Induced Fatal Thrombocytopenia in a 47 Years Old Egyptian Patient. Gen Med (Los Angeles) 4:e111
Kelleni MT (2016): A rapid and successful corticosteroid based approach used to treat resistant Alopecia
Areata Sisaipho in a 7 years old Egyptian girl; when pediatrics equals grace. Ped Health Res. 1:1.
Mina TK (2016): Amyloid Deposits: a Possible Link between Type 2 Diabetes Mellitus and Cancer. Diabetes Obes Int J 1(6): 000131.
Kelleni MT (2016): Rituximab: Is it Possible to Link Both Autoimmune Haemolytic Anemia and Aplastic Anemia Regarding the Etiology and Management? Gen Med (Los Angeles) 4:e110. Doi:10.4172/2327-5146.1000e110
Kelleni MT (2016): Simeprevir, Sofosbuvir and Ribavirin as First Line Therapy of HCV Infection, is it Justifiable Enough Basing on Safety and Efficacy. Gen Med (Los Angel) 4:e109. Doi:10.4172/2327-5146.1000e109
Mina TKelleni (2016): Amyloid Antagonists: The Future of Type 2 Diabetes as Well as Several Neurodegenerative Diseases Treatments. Dia Obe Int Jo. 1(2): 000106. Mina T Kelleni (2016): Cefotaxime Used as Paracetamol- Antibiotic Resistance in Developing Countries, A Global Upcoming Catastrophe Unless Urgently Addressed. Journal of Prevention & Infection Control 2(1): 14.
Mina T Kelleni, Salwa A Ibrahim and Aly M Abdelrahman (2016): Effect of captopril and telmisartan on methotrexate-induced hepatotoxicity in rats: impact of oxidative stress, inflammationand apoptosis. Toxicol Mech Method. DOI: 10.1080/15376516.2016.1191576
Kelleni MT (2016) Chamomile Tea Potentials in Prevention and Amelioration of Type 2 Diabetes Mellitus. J Diabetes Metab 7:649. DOI:10.4172/2155-6156.1000649
Mina ThabetKelleni, Entesar F. Amin, Aly M. Abdelrahman (2015): Effect of Metformin and Sitagliptin on Doxorubicin-induced Cardiotoxicity in Rats: Impact of Oxidative Stress, Inflammation and Apoptosis. J Toxicol, Article ID 424813, 8 pages.
Kelleni MT (2015) Pioglitazone and Sitagliptin: An Urgent Call for New Regulations Controlling all the Post Marketing Drug Safety Studies. Endocrinol Metab Int J 2(4): 00029. DOI: 10.15406/emij.2015.02.00029
Mina TKelleni (2015) A Peculiar Juvenile Progressive Systemic Sclerosis Case Report: The Egyptian versus the International Approach of Treatment. Gen Med (Los Angel) S2:005. DOI:10.4172/2327-
Kelleni MT (2015) Fludarabine Monotherapy Fails to Control a Case of Relapsing Non-Hodgkin’s Lymphoma. Gen Med (Los Angel) 3:204. DOI:10.4172/2327-5146.1000204
Kelleni MT (2015) Together towards an early global detection of type 2 diabetes using a simplified metabolomics’ test. Integr Obesity Diabetes. 1: DOI: 10.15761/IOD.1000121
Kelleni MT (2014) Pioglitazone: How Pharmacology Can be used Interchangeably with Mammonology in the Developing Countries? J Diabetes Metab 5 (8):411
Mohamed Ibrahim, MinaKelleni, Ayman Geddawy (2013) Nonalcoholic fatty liver disease: Current and potential therapies. Life Sci. 7; 92(2):114-8.
Mohamed Ibrahim, Entesar Farghaly, Wafaey Gomaa, MinaKelleni, Aly Mohamed Abdelrahman (2011) Nitro-aspirin is a potential therapy for non alcoholic fatty liver disease. Eur J Pharm, 659: 289-295.
Mohamed Ibrahim, Entesar Farghaly, Wafaey Gomaa, Mina Kelleni, Aly Abdelrahman (2010) Ezetimibe inhibitsproinflammatory mediators involved in the pathogenesis of non alcoholic fatty liver disease. Egypt. J. Med Sci, 31 (1): 247-269.